β(6)-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma

INTRODUCTION: Despite enormous efforts during the past decades, pancreatic adenocarcinoma (PAC) remains one of the most deleterious cancer entities. A useful biomarker for early detection or prognosis of PAC does not yet exist. The goal of our study was the characterization of β(6)-integrin (ITGB6)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenggenhager, Daniela, Bengs, Susan, Fritsch, Ralph, Hussung, Saskia, Busenhart, Philipp, Endhardt, Katharina, Töpfer, Antonia, The, Frans Olivier, Bütikofer, Simon, Gubler, Christoph, Scharl, Michael, Morell, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367066/
https://www.ncbi.nlm.nih.gov/pubmed/34388137
http://dx.doi.org/10.14309/ctg.0000000000000395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367066/
https://www.ncbi.nlm.nih.gov/pubmed/34388137
http://dx.doi.org/10.14309/ctg.0000000000000395

Ejemplares similares